AKT1 and cancer: PI3K/AKT pathway is altered in many cancer types, causing enhanced activation of signaling cascades associated with excessive cellular growth, proliferation, and survival, acting on a varied range of downstream effectors, including murine double minutes 2 (Mdm2), FOXO, and SK-3,6 [31].